News
February 3, 2020
FairJourney Biologics Receives Investment from GHO Capital Partners
DEAL ALERT
January 8, 2020
Shield Therapeutics Enters into Exclusive License with Beijing Aosaikang Pharmaceutical in China
PRESS RELEASE | DEAL ALERT
November 5, 2019
Cobra Biologics to be Acquired by Cognate BioServices
PRESS RELEASE | DEAL ALERT
June 13, 2019
4WEB Medical completes financing with SWK Holdings
PRESS RELEASE | DEAL ALERT
June 10, 2019
Calliditas and Everest Medicines Enter into a Licensing Agreement for Nefecon in Greater China and Singapore for up to $121 million
PRESS RELEASE | DEAL ALERT
April 1, 2019
Mustang Bio closes $20 million venture debt financing with Horizon Technology Finance Corporation
PRESS RELEASE | DEAL ALERT
March 25, 2019
Saama Closes $40 Million Financing with Perceptive Advisors
PRESS RELEASE | DEAL ALERT
February 7, 2019
Update on Torreya's recent activities in capital markets — raising capital for clients via equity, debt, and royalty monetizations for growth, liquidity, and acquisition financing
VIEW MORE
February 4, 2019
Torreya advised Indivior PLC to divest its rights related to the Sai Bo SongTM (buprenorphine, naloxone) tablet in China to Zhejiang Pukang Biotechnology Co., Ltd. for a total consideration of up to $122.5 million
PRESS RELEASE | DEAL ALERT
February 4, 2019
Simbec-Orion Sale of Majority Stake to CBPE Capital
PRESS RELEASE | DEAL ALERT
January 16, 2019
Mid-Atlantic Dental Partners Secures $70 Million Credit Facility from CRG
PRESS RELEASE | DEAL ALERT
December 23, 2018
Luoxin Pharmaceutical and Aurobindo Pharma Announce Strategic Partnership to Establish Joint Venture in China on High Quality and Affordable Pharmaceuticals
PRESS RELEASE
December 20, 2018
Summary of Torreya's activities in 2018, highlighting advisory activities of the US Strategic, Europe, Asia Pacific, and Capital Markets teams
VIEW MORE
December 17, 2018
Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies
PRESS RELEASE | DEAL ALERT
November 13, 2018
Avenue Therapeutics Announces Sale of Stock and Conditional Sale to Cipla
PRESS RELEASE
November 13, 2018
Update on Torreya's recent activities in Europe including mergers & acquisitions, asset sales & licensing, and capital markets advisory
VIEW MORE
October 15, 2018
Lysogene Announces Licensing Agreement for LYS-SAF302, a Late-stage Gene Therapy, to Sarepta for the US and Markets Outside of Europe
PRESS RELEASE | DEAL ALERT
September 27, 2018
Midatech Announces Proposed Sale of Midatech Pharma US, Inc.
PRESS RELEASE | DEAL ALERT
September 24, 2018
Tris Pharma Announces Debt Recapitalization with Deerfield and Acquisition of NextWave Pharmaceuticals
PRESS RELEASE | DEAL ALERT
September 21, 2018
Xoma Acquires Royalty Interest Position For 7 Assets From Agenus
PRESS RELEASE | DEAL ALERT
September 19, 2018
Shield Therapeutics and Norgine enter into an exclusive license agreement for Feraccru® in Europe, Australia and New Zealand
PRESS RELEASE | DEAL ALERT
June 11, 2018
EA Pharma licenses rights to AJT-240 in China to Tasly Pharmaceutical
PRESS RELEASE | DEAL ALERT
June 7, 2018
Onxeo S.A. Secures $7.5 Million of Non-Dilutive Capital from SWK Holdings Corporation Through the Partial Sale of Future Beleodaq® Royalties
PRESS RELEASE | DEAL ALERT
June 7, 2018
Standard Homeopathic Company Secures $40 Million Credit Facility from Hayfin
DEAL ALERT
June 5, 2018
Edenbridge sale of Yargesa to Piramal
DEAL ALERT
May 23, 2018
Epigen Biosciences Licenses its LPA1 Receptor small molecule program to Novo Nordisk
PRESS RELEASE | DEAL ALERT
April 26, 2018
Somerset Therapeutics and Affiliate Wintac, Limited to be Acquired by Endo
PRESS RELEASE | DEAL ALERT
March 30, 2018
pSivida Acquires Icon Bioscience, Rebrands as EyePoint Pharmaceuticals, and Raises both Equity and Debt Capital
PRESS RELEASE | DEAL ALERT
January 19, 2018
Bio-Pharm Acquired by Torrent Pharma
PRESS RELEASE | DEAL ALERT
December 18, 2017
Neuland Laboratories Completes Acquisition of API Facility from Arch Pharmalabs
PRESS RELEASE | DEAL ALERT
November 17, 2017
Cerecor Acquires TRx Pharmaceuticals
PRESS RELEASE | DEAL ALERT
November 15, 2017
CombiMatrix Successfully Completes Transformation Merger with Invitae
PRESS RELEASE | DEAL ALERT
November 14, 2017
Crown Laboratories to Sell Major Stake to Hildred Capital Partners
PRESS RELEASE | DEAL ALERT
October 24, 2017
Torreya’s in-depth study of the future of the pharmaceutical industry reveals the sector is larger and faster-growing than previously thought.
VIEW MORE
July 27, 2017
Update on Torreya’s recent activity advising on M&A, capital markets, and licensing transactions
VIEW MORE
July 26, 2017
Accord Healthcare Announces Acquisition of Essential Pharmaceuticals
PRESS RELEASE | DEAL ALERT
June 14, 2017
JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.
PRESS RELEASE | DEAL ALERT
April 20, 2017
Japan’s Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher‐Smith Laboratories
PRESS RELEASE | DEAL ALERT
January 30, 2017
Mallinckrodt To Sell Intrathecal Therapy Business To Piramal Enterprises Limited For Approximately $203 Million
PRESS RELEASE | DEAL ALERT
December 21, 2016
XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update
PRESS RELEASE
December 15, 2016
Opiant Pharmaceuticals, Inc. Announces NARCAN Nasal Spray Royalty Monetization
PRESS RELEASE
October 25, 2016
Everstone Capital Invests Rs 220 Crore in Rubicon Research
PRESS RELEASE
August 5, 2016
IntelGenx Announces Sale of Forfivo XL(R) Royalty for $6 Million
PRESS RELEASE
July 11, 2016
New Mountain Capital Partners with Topix Pharmaceuticals
PRESS RELEASE
May 13, 2016
WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement
PRESS RELEASE | DEAL ALERT
February 29, 2016
Hikma Announces the Close of the Roxane Laboratories Acquisition
PRESS RELEASE
February 1, 2016
ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million
PRESS RELEASE
December 23, 2015
Agenus Acquires PhosImmune with a Novel Class of Cancer Neoantigens
PRESS RELEASE
November 17, 2015
Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm
PRESS RELEASE
November 5, 2015
XOMA Announces the Sale of Its Manufacturing Facilities to Agenus
PRESS RELEASE
November 5, 2015
XOMA divests biodefense program to Nanotherapeutics, Inc.
PRESS RELEASE
October 13, 2015
IGI Laboratories, Inc. Enters Into Agreement To Acquire The Assets Of Canadian Pharmaceutical Company, Alveda Pharmaceuticals, Inc.
PRESS RELEASE
October 1, 2015
XOMA Announces Development and Commercialization Agreement for First-in-Class Anti-TGF-beta Antibody Program in Immuno-Oncology
PRESS RELEASE
July 28, 2015
Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
PRESS RELEASE
July 13, 2015
ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million
PRESS RELEASE
June 9, 2015
Mission Pharmacal Acquires ProSolus Pharmaceuticals
PRESS RELEASE
June 4, 2015
DARA BioSciences (DARA), Midatech Pharma Enter Merger Agreement
PRESS RELEASE
May 21, 2015
arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions
PRESS RELEASE
May 19, 2015
Ipsen strengthens its presence in the oncology field with the acquisition of OctreoPharm Sciences, a company developing innovative radiopharmaceuticals for the diagnosis and treatment of neuroendocrine tumours
PRESS RELEASE
March 18, 2015
Prestium Pharma, Inc. Acquires ZONALON® (Doxepin Hydrochloride), 5% Cream; Continues to Expand its Product Portfolio
PRESS RELEASE
March 5, 2015
TRIANEX® 0.05%(Triamcinolone Acetonide Ointment,USP) Now Available from Promius Pharma, LLC
PRESS RELEASE
January 6, 2015
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
PRESS RELEASE
December 16, 2014
Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited Subsidiary
PRESS RELEASE
December 15, 2014
Aseptix signs global technology license with Ecolab
PRESS RELEASE
November 24, 2014
Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB
PRESS RELEASE
November 3, 2014
PDI Expands Molecular Diagnostics Business with RedPath Integrated Pathology Acquisition
PRESS RELEASE
October 23, 2014
Probiodrug raises €22.5 million in successful Initial Public Offering and listing on Euronext Amsterdam
PRESS RELEASE
October 23, 2014
Medivation Inc. Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. for Potential Applications in Oncology
PRESS RELEASE
October 22, 2014
DBV Technologies S.A. Announces Pricing of Global Offering
PRESS RELEASE
October 16, 2014
Molecular Imaging Firm Raises $15M for Global Expansion
PRESS RELEASE
July 30, 2014
First Generation Capital to maintain 23.7% Trimel ownership following new financing
PRESS RELEASE
July 17, 2014
Trimel Pharmaceuticals Acquires Canadian Rights to Estrace®
PRESS RELEASE
May 19, 2014
Ventrus Biosciences to Merge With Assembly Pharmaceuticals
PRESS RELEASE
May 8, 2014
Lundbeck to acquire Chelsea Therapeutics
PRESS RELEASE
May 2, 2014
Shire Acquires Fibrotech For US$75 Million
PRESS RELEASE
March 20, 2014
Concordia Healthcare Announces Agreement to Acquire Donnatal
PRESS RELEASE
February 28, 2014
Compugen Ltd. Prices Public Offering of Ordinary Shares
PRESS RELEASE
February 20, 2014
DenMat, the Makers of Lumineers, Acquires Substantially All Dental Assets of Zila, Inc.
PRESS RELEASE
February 19, 2014
Torreya Partners Announces Three Executive Promotions
PRESS RELEASE
November 25, 2013
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
PRESS RELEASE
November 18, 2013
Cardiome to Acquire Correvio LLC
PRESS RELEASE
November 14, 2013
DBV Technologies announces the completion of a €29.9m private placement with a majority placed with US investors
PRESS RELEASE
September 30, 2013
Stratus Media Group Enters Dermatological and Restorative Medicine Industry, Signs Merger Agreement With Two Biopharmaceutical Companies, Changes Corporate Name To Restorgenex Corporation, and Announces New Chairman and Vice Chairman
PRESS RELEASE
August 20, 2013
PDI, Inc. Enters into Collaboration Agreement to Commercialize Molecular Diagnostic Tests
PRESS RELEASE
August 5, 2013
Bayer Enters Cancer Research Deal with Compugen
PRESS RELEASE
July 18, 2013
Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)
PRESS RELEASE
May 7, 2013
SHIONOGI INC. DIVESTS AND EXCLUSIVELY LICENSES ITS PEDIATRIC PRODUCTS TO CONCORDIA PHARMACEUTICALS INC.
PRESS RELEASE
April 30, 2013
Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
PRESS RELEASE
March 11, 2013
CLINIGEN Clinigen Group and Theravance Entered into Exclusive Commercialization Agreement in the EU for Antibacterial VIBATIV
PRESS RELEASE
January 22, 2013
Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline
PRESS RELEASE
October 1, 2012
ProStrakan Acquires Breast Cancer Product for the US
PRESS RELEASE
August 27, 2012
Merz, Inc. Announces the Acquisition of CUVPOSA® (glycopyrrolate) Oral Solution, First and Only FDA-Approved Treatment for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
PRESS RELEASE
June 21, 2012
Depomed Announces Acquisition Of Zipsor® (diclofenac potassium) From Xanodyne Pharmaceuticals, Inc.
PRESS RELEASE
July 15, 2011
NeoStem to acquire Amorcyte
PRESS RELEASE
May 27, 2011
PHARMASCIENCE ACQUIRES AEGERA THERAPEUTICS
PRESS RELEASE
April 4, 2011
Royalty Pharma Acquires Lexiscan® and Cubicin® Royalties for $487 Million
PRESS RELEASE
December 20, 2010
Lpath Grants Pfizer Exclusive Option for Worldwide License for iSONEP
PRESS RELEASE
October 25, 2010
Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals
PRESS RELEASE
July 30, 2010
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB, INC.
PRESS RELEASE
July 2, 2010
Watson Completes Acquisition of CRINONE(R) and PROCHIEVE(R) Product Line and Shares of Columbia Laboratories
PRESS RELEASE
July 1, 2010
Euthymics Bioscience, Inc. and DOV Pharmaceutical, Inc. Announce Merger Agreement
PRESS RELEASE
June 23, 2010
Thorne Research Announces Combination with Diversified Natural Products
PRESS RELEASE